BIX augmented the levels of endogenous Beclin-1 in a time-dependent manner in the MCF-7 (Beclin-1+/−) and HS578T (Beclin-1+/+) breast cancer cell lines (Figure 1b). This evidence concerns the gene BECN1 and breast carcinoma.